Intellia Therapeutics Statistics
Total Valuation
NTLA has a market cap or net worth of $2.05 billion. The enterprise value is $1.25 billion.
| Market Cap | 2.05B |
| Enterprise Value | 1.25B |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, before market open.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NTLA has 96.11 million shares outstanding. The number of shares has increased by 15.33% in one year.
| Shares Outstanding | 96.11M |
| Shares Change (YoY) | +15.33% |
| Shares Change (QoQ) | +2.06% |
| Owned by Insiders (%) | 1.33% |
| Owned by Institutions (%) | 87.43% |
| Float | 94.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 56.48 |
| Forward PS | 38.33 |
| PB Ratio | 1.95 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 34.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.67, with a Debt / Equity ratio of 0.11.
| Current Ratio | 8.67 |
| Quick Ratio | 8.23 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.90% and return on invested capital (ROIC) is -44.21%.
| Return on Equity (ROE) | -43.90% |
| Return on Assets (ROA) | -36.40% |
| Return on Capital (ROIC) | -44.21% |
| Revenue Per Employee | $68,964 |
| Profits Per Employee | -$914,814 |
| Employee Count | 526 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.58% in the last 52 weeks. The beta is 1.80, so NTLA's price volatility has been higher than the market average.
| Beta (1Y) | 1.80 |
| 52-Week Price Change | -43.58% |
| 50-Day Moving Average | 27.31 |
| 200-Day Moving Average | 31.24 |
| Relative Strength Index (RSI) | 26.59 |
| Average Volume (30 Days) | 1,557,879 |
Short Selling Information
The latest short interest is 14.83 million, so 15.43% of the outstanding shares have been sold short.
| Short Interest | 14.83M |
| Short Previous Month | 13.50M |
| Short % of Shares Out | 15.43% |
| Short % of Float | 15.69% |
| Short Ratio (days to cover) | 9.54 |
Income Statement
In the last 12 months, NTLA had revenue of $36.28 million and -$481.19 million in losses. Loss per share was -$5.42.
| Revenue | 36.28M |
| Gross Profit | 36.28M |
| Operating Income | -515.29M |
| Pretax Income | -481.19M |
| Net Income | -481.19M |
| EBITDA | -472.22M |
| EBIT | -481.19M |
| Loss Per Share | -$5.42 |
Balance Sheet
The company has $912.22 million in cash and $115.35 million in debt, giving a net cash position of $796.88 million or $8.29 per share.
| Cash & Cash Equivalents | 912.22M |
| Total Debt | 115.35M |
| Net Cash | 796.88M |
| Net Cash Per Share | $8.29 |
| Equity / Book Value | 1.05B |
| Book Value Per Share | 10.93 |
| Working Capital | 883.12M |
Cash Flow
In the last 12 months, operating cash flow was -$394.09 million and capital expenditures -$13.99 million, giving a free cash flow of -$408.07 million.
| Operating Cash Flow | -394.09M |
| Capital Expenditures | -13.99M |
| Free Cash Flow | -408.07M |
| FCF Per Share | -$4.60 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,420.51% and -1,326.51%.
| Gross Margin | 100.00% |
| Operating Margin | -1,420.51% |
| Pretax Margin | -1,326.51% |
| Profit Margin | -1,326.51% |
| EBITDA Margin | -1,301.77% |
| EBIT Margin | -1,326.51% |
| FCF Margin | -1,124.94% |
Dividends & Yields
NTLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.33% |
| Shareholder Yield | -15.33% |
| Earnings Yield | -23.48% |
| FCF Yield | -19.92% |
Analyst Forecast
The average price target for NTLA is $70.62, which is 231.24% higher than the current price. The consensus rating is "Buy".
| Price Target | $70.62 |
| Price Target Difference | 231.24% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 118.99% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NTLA has an Altman Z-Score of 2.74 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.74 |
| Piotroski F-Score | 2 |